Three unique UGT2B17 peptides constitute minor human leukocyte antigens responsible for graft-vs-host diseases (GVHD) after allogeneic bone marrow transplant in donor-recipient mismatch for the UGT2B17 gene [26, 27]. The gene discussed is UGT2B17; the disease is graft versus host disease.